Literature DB >> 25537798

Mesenteric lymph duct drainage attenuates acute lung injury in rats with severe intraperitoneal infection.

Yanmin Zhang1, Shukun Zhang, Naiqiang Tsui.   

Abstract

The purpose of this study is to investigate the hypothesis that the mesenteric lymphatic system plays an important role in acute lung injury in a rat model induced by severe intraperitoneal infection. Male Wistar rats weighing 250∼300 g were randomly divided into 3 groups and subjected to sham operation, intraperitoneal infection, or mesenteric lymphatic drainage. The activity of diamine oxidase (DAO) and myeloperoxidase (MPO) were measured by enzymatic assay. The endotoxin levels in plasma, lymph, and bronchoalveolar lavage fluid (BALF) were evaluated using the limulus amoebocyte lysate reagent. The cytokines, adhesion factors, chemokines, and inflammatory factors were detected by ELISA. TLR-4, NF-kB, and IRAK-4 were analyzed by Western blotting. Compared with sham-operated rats, rats with intraperitoneal infection had increased MPO and decreased DAO activity in intestinal tissues. Mesenteric lymph drainage reduced the alterations in MPO and DAO activity induced by intraperitoneal infection. The MPO activity in pulmonary tissue and the permeability of pulmonary blood vessels were also increased, which were partially reversed by mesenteric lymph drainage. The endotoxin levels in lymphatic fluid and alveolar perfusion fluid were elevated after intraperitoneal infection but decreased to control levels after lymph drainage. No alterations in the levels of plasma endotoxin were observed. The number of neutrophils was increased in BALF and lymph in the infected rats, and was also reduced after drainage. Lymph drainage also decreased the levels of inflammatory cytokines, chemokines, and adhesion factors in the plasma, lymph, and BALF, as well as the levels of TLR-4, NF-kB, and IRAK-4 in pulmonary and intestinal tissues. The mesenteric lymphatic system is the main pathway involved in early lung injury caused by severe intraperitoneal infection, in which activation of the TLR-4 signal pathway may play a role.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25537798     DOI: 10.1007/s10753-014-0091-z

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  32 in total

1.  Time-dependent reversal of sepsis-induced PMN uptake and lung vascular injury by expression of CD18 antagonist.

Authors:  Ning Xu; Xiao-Pei Gao; Richard D Minshall; Arshad Rahman; Asrar B Malik
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-04       Impact factor: 5.464

Review 2.  Role of the gut lymphatic system in multiple organ failure.

Authors:  E A Deitch
Journal:  Curr Opin Crit Care       Date:  2001-04       Impact factor: 3.687

3.  Accuracy of three-dimensional CT angiography for preoperative vascular evaluation of laparoscopic living renal donors.

Authors:  Srinivas Rajamahanty; Robert Simon; Michael Edye; Khalid Butt; Majid Eshghi
Journal:  J Endourol       Date:  2005-04       Impact factor: 2.942

4.  Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region.

Authors:  A Poltorak; I Smirnova; X He; M Y Liu; C Van Huffel; O McNally; D Birdwell; E Alejos; M Silva; X Du; P Thompson; E K Chan; J Ledesma; B Roe; S Clifton; S N Vogel; B Beutler
Journal:  Blood Cells Mol Dis       Date:  1998-09       Impact factor: 3.039

5.  Urinary trypsin inhibitor attenuates lipopolysaccharide-induced acute lung injury by blocking the activation of p38 mitogen-activated protein kinase.

Authors:  Xinying Zhang; Fengqin Liu; Haiyan Liu; Hongxia Cheng; Wei Wang; Qiang Wen; Yulin Wang
Journal:  Inflamm Res       Date:  2011-01-19       Impact factor: 4.575

Review 6.  Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS)

Authors:  R C Bone
Journal:  Ann Intern Med       Date:  1996-10-15       Impact factor: 25.391

7.  The release of interleukin-1 beta (IL-1) precedes that of interleukin 6 (IL-6) in patients undergoing major surgery.

Authors:  R J Baigrie; P M Lamont; M Dallman; P J Morris
Journal:  Lymphokine Cytokine Res       Date:  1991-08

8.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

Review 9.  Multiple organ failure. Pathophysiology and potential future therapy.

Authors:  E A Deitch
Journal:  Ann Surg       Date:  1992-08       Impact factor: 12.969

10.  CB2 cannabinoid receptors contribute to bacterial invasion and mortality in polymicrobial sepsis.

Authors:  Balázs Csóka; Zoltán H Németh; Partha Mukhopadhyay; Zoltán Spolarics; Mohanraj Rajesh; Stephanie Federici; Edwin A Deitch; Sándor Bátkai; Pál Pacher; György Haskó
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

View more
  3 in total

1.  Gut Ischemia Reperfusion Injury Induces Lung Inflammation via Mesenteric Lymph-Mediated Neutrophil Activation.

Authors:  Yonggang Ma; Taylor Zabell; Alexandra Creasy; Xiaoyuan Yang; Victor Chatterjee; Nuria Villalba; Erik B Kistler; Mack H Wu; Sarah Y Yuan
Journal:  Front Immunol       Date:  2020-09-11       Impact factor: 7.561

2.  Mesenteric Lymph Duct Ligation Alleviates Acute Lung Injury Caused by Severe Acute Pancreatitis Through Inhibition of High Mobility Group Box 1-Induced Inflammation in Rats.

Authors:  Yishuang Tang; Jing Kong; Bingduo Zhou; Xiaosu Wang; Xiaowen Liu; Yi Wang; Shengliang Zhu
Journal:  Dig Dis Sci       Date:  2021-01-12       Impact factor: 3.199

Review 3.  The Gut-Lung Axis in Systemic Inflammation. Role of Mesenteric Lymph as a Conduit.

Authors:  Yonggang Ma; Xiaoyuan Yang; Victor Chatterjee; Mack H Wu; Sarah Y Yuan
Journal:  Am J Respir Cell Mol Biol       Date:  2021-01       Impact factor: 6.914

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.